◆英語タイトル:Opiant Pharmaceuticals Inc (OPNT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7108
◆発行会社(調査会社):
GlobalData
◆発行日:2018年10月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Opiant Pharmaceuticals Inc (Opiant), formerly, Lightlake Therapeutics Inc is a specialty pharmaceutical company that develops pharmacological treatments for substance use, addiction and eating disorders. It focuses on developing treatments to reverse opioid overdoses, for overweight and obese patients with binge eating disorder (BED), and for cocaine use disorder. The company develops products based on its patented novel opioid antagonist nasal delivery technology. Opiant developed NARCAN (naloxone hydrochloride) nasal spray, a treatment to reverse opioid overdose. The product is approved for marketing in the US by its partner, Adapt Pharma. The company is also developing opioid antagonists with a near term focus on cocaine use disorder, binge eating disorder (BED) and bulimia nervosa. Opiant is headquartered in Santa Monica, California, the US.
Opiant Pharmaceuticals Inc (OPNT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Opiant Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Opiant Pharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Opiant Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Opiant Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Opiant Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Opiant Pharmaceuticals Inc, Medical Equipment, Deal Details 10
Equity Offering 10
Opiant Pharma Raises USD13.8 Million in Public Offering of Shares 10
Opiant Pharma Raises USD12 Million in Public Offering of Shares 12
Opiant Pharma Raises USD5.3 Million in Private Placement of Shares up on Exercise of Warrants 13
Opiant Pharma Plans to Raise up to USD150 Million in Public Offering of Shares 14
Opiant Pharmaceuticals Inc – Key Competitors 15
Opiant Pharmaceuticals Inc – Key Employees 16
Opiant Pharmaceuticals Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Financial Announcements 18
Aug 09, 2018: Opiant Pharmaceuticals reports second quarter 2018 financial results and provides corporate update 18
May 08, 2018: Opiant Pharmaceuticals Announces First Quarter 2018 Financial Results 20
Mar 07, 2018: Opiant Pharmaceuticals Reports Financial Results for August 1, 2017, Through December 31, 2017, and Provides Corporate Update 21
Dec 04, 2017: Opiant Pharmaceuticals Reports Fiscal First Quarter 2018 Financial Results 22
Oct 13, 2017: Opiant Pharmaceuticals Reports Fiscal Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update 23
Jun 15, 2017: Opiant Pharmaceuticals Reports Fiscal Third Quarter 2017 Financial Results and Provides Corporate Update 25
Mar 16, 2017: Opiant Pharmaceuticals Reports Fiscal Second Quarter 2017 Financial Results and Provides Corporate Update 27
Research And Development 28
Sep 12, 2018: Consort to develop delivery device for opioid overdose drug 28
Corporate Communications 29
Jun 12, 2018: Opiant Pharmaceuticals Names Richard Daly As Board Director 29
Sep 05, 2017: Opiant Pharmaceuticals Announces Appointment of David O’Toole as Chief Financial Officer 30
Feb 06, 2017: Opiant Pharmaceuticals Announces the Appointment of Dr. Phil Skolnick as Chief Scientific Officer 31
Legal and Regulatory 32
Aug 28, 2017: Opiant Pharmaceuticals Announces Listing on the Nasdaq Capital Market 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33
List of Tables
Opiant Pharmaceuticals Inc, Medical Equipment, Key Facts, 2017 2
Opiant Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Opiant Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Opiant Pharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Opiant Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Opiant Pharmaceuticals Inc, Deals By Market, 2012 to YTD 2018 8
Opiant Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Opiant Pharma Raises USD13.8 Million in Public Offering of Shares 10
Opiant Pharma Raises USD12 Million in Public Offering of Shares 12
Opiant Pharma Raises USD5.3 Million in Private Placement of Shares up on Exercise of Warrants 13
Opiant Pharma Plans to Raise up to USD150 Million in Public Offering of Shares 14
Opiant Pharmaceuticals Inc, Key Competitors 15
Opiant Pharmaceuticals Inc, Key Employees 16
Opiant Pharmaceuticals Inc, Subsidiaries 17
List of Figures
Opiant Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Opiant Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Opiant Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Opiant Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Opiant Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Opiant Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Opiant Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Opiant Pharmaceuticals Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8